T1	PROC 46 66	Ensayo Multinacional
T2	DISO 93 123	Síndrome de Opsoclono Mioclono
#1	AnnotatorNotes T2	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
T3	DISO 151 154	SOM
T4	DISO 125 150	Síndrome del Ojo Danzante
T5	ANAT 138 141	Ojo
#2	AnnotatorNotes T5	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T6	DISO 155 158	SOD
T7	DISO 182 212	Síndrome de Opsoclono Mioclono
#4	AnnotatorNotes T7	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
T8	DISO 279 282	SOM
T9	DISO 577 580	SOM
T10	DISO 215 240	Síndrome del Ojo Danzante
T11	ANAT 228 231	Ojo
#5	AnnotatorNotes T11	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T12	DISO 283 286	SOD
T13	PROC 296 307	diagnóstico
#7	AnnotatorNotes T13	C0011900; Diagnosis; Diagnostic Procedure
T14	DISO 313 315	NB
#8	AnnotatorNotes T14	C0027819; Neuroblastoma; Neoplastic Process | C2931189; Neural crest tumor; Disease or Syndrome
T15	DISO 1219 1222	SOM
T16	PROC 400 411	tratamiento
#9	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 419 442	tratamiento corticoideo
T18	CHEM 466 478	dexametasona
#10	AnnotatorNotes T18	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T19	PROC 526 540	ensayo clínico
#11	AnnotatorNotes T19	C0008976; Clinical Trials; Research Activity
T20	DISO 581 584	SOD
T21	DISO 585 587	NB
#13	AnnotatorNotes T21	C0027819; Neuroblastoma; Neoplastic Process | C2931189; Neural crest tumor; Disease or Syndrome
T22	DISO 608 621	neuroblastoma
#14	AnnotatorNotes T22	C0027819; Neuroblastoma; Neoplastic Process | C2931189; Neural crest tumor; Disease or Syndrome
T23	PROC 661 675	ensayo clínico
#15	AnnotatorNotes T23	C0008976; Clinical Trials; Research Activity
T24	PROC 729 740	tratamiento
#16	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	PROC 759 773	ensayo clínico
#17	AnnotatorNotes T25	C0008976; Clinical Trials; Research Activity
T26	DISO 860 869	opsoclono
#18	AnnotatorNotes T26	C0242567; Opsoclonus; Disease or Syndrome
T27	DISO 884 890	ataxia
#19	AnnotatorNotes T27	C0004134; Ataxia; Sign or Symptom
T28	DISO 908 918	enfermedad
#20	AnnotatorNotes T28	C0012634; Disease; Disease or Syndrome
T29	DISO 930 954	infección activa del SNC
T30	ANAT 951 954	SNC
#21	AnnotatorNotes T30	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T31	DISO 956 983	trastornos neurometabólicos
T32	DISO 986 1002	desmielinización
#22	AnnotatorNotes T32	C0011304; Demyelination; Pathologic Function
T33	DISO 1030 1045	infección viral
#23	AnnotatorNotes T33	C0042769; Virus Diseases; Disease or Syndrome
T34	PROC 1087 1100	quimioterapia
#24	AnnotatorNotes T34	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T35	PROC 1156 1167	tratamiento
#25	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	DISO 1172 1185	neuroblastoma
#26	AnnotatorNotes T36	C0027819; Neuroblastoma; Neoplastic Process | C2931189; Neural crest tumor; Disease or Syndrome
T37	PROC 1190 1213	Tratamiento corticoideo
T38	DISO 1223 1226	SOD
T39	PROC 1307 1333	tratamiento estándardizado
T40	CHEM 1368 1379	corticoides
#28	AnnotatorNotes T40	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T41	PROC 696 720	consentimiento informado
#29	AnnotatorNotes T41	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T42	DISO 323 325	NB
#30	AnnotatorNotes T42	C0027819; Neuroblastoma; Neoplastic Process | C2931189; Neural crest tumor; Disease or Syndrome
T43	CHEM 431 442	corticoideo
#31	AnnotatorNotes T43	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T44	DISO 871 881	mioclonias
#32	AnnotatorNotes T44	C0027063; Myoclonic disorder; Disease or Syndrome | C0027066; Myoclonus; Sign or Symptom
T45	CHEM 1202 1213	corticoideo
#33	AnnotatorNotes T45	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T46	Date 13 17	2011
T47	LIVB 80 85	niños
#34	AnnotatorNotes T47	C0008059; Child; Age Group
T48	LIVB 269 274	Niños
#35	AnnotatorNotes T48	C0008059; Child; Age Group
T49	Age 337 366	mayor de 6 meses hasta 8 años
T50	Age 368 383	< 8º cumpleaños
T51	Route 456 462	pulsos
#36	AnnotatorNotes T51	C0391850; Physiologic pulse; Physiologic Function
T52	LIVB 551 560	pacientes
#37	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Spec_cue 565 576	sospecha de
T54	LIVB 782 788	padres
#38	AnnotatorNotes T54	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T55	LIVB 791 813	representantes legales
#39	AnnotatorNotes T55	C4288823; Legal Representative for the Study; Human
T56	LIVB 846 855	pacientes
#40	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Neg_cue 1046 1048	no
T58	Duration 1388 1404	menos de 14 días
T59	LIVB 1040 1045	viral
#41	AnnotatorNotes T59	C0042776; Virus; Virus
T60	Neg_cue 326 329	neg
T61	Neg_cue 588 591	neg
T62	Neg_cue 598 607	excluírse
T63	Duration 1255 1268	14 o más días
A1	Population_data T47 Age
A2	Population_data T48 Age
A3	Assertion T42 Negated
A4	Assertion T21 Negated
A5	Assertion T9 Speculated
A6	Assertion T20 Speculated
A7	Assertion T22 Negated
A8	Assertion T33 Negated
A9	Status T34 History_of
#43	AnnotatorNotes T3	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome 
#3	AnnotatorNotes T8	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#6	AnnotatorNotes T9	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#12	AnnotatorNotes T15	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#27	AnnotatorNotes T29	C0007684; Central Nervous System Infection; Disease or Syndrome 
R1	Experiences Arg1:T47 Arg2:T2	
R2	Experiences Arg1:T47 Arg2:T4	
#42	AnnotatorNotes T4	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#44	AnnotatorNotes T6	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#45	AnnotatorNotes T10	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#46	AnnotatorNotes T12	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#47	AnnotatorNotes T20	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
#48	AnnotatorNotes T38	C0393626; Opsoclonus-Myoclonus Syndrome; Disease or Syndrome
R3	Location_of Arg1:T5 Arg2:T4	
R4	Location_of Arg1:T5 Arg2:T2	
R5	Location_of Arg1:T5 Arg2:T3	
R6	Location_of Arg1:T5 Arg2:T6	
R7	Location_of Arg1:T11 Arg2:T10	
R8	Location_of Arg1:T11 Arg2:T7	
R9	Experiences Arg1:T47 Arg2:T3	
R10	Experiences Arg1:T47 Arg2:T6	
R11	Experiences Arg1:T48 Arg2:T8	
R12	Experiences Arg1:T48 Arg2:T12	
R13	Negation Arg1:T60 Arg2:T42	
T64	Result_or_Value 316 319	pos
#49	AnnotatorNotes T64	C1446409; Positive; Finding
R14	Has_Result_or_Value Arg1:T14 Arg2:T64	
R15	Experiences Arg1:T48 Arg2:T14	
R16	Experiences Arg1:T48 Arg2:T42	
R17	Overlap Arg1:T8 Arg2:T14	
R18	Overlap Arg1:T8 Arg2:T42	
R19	Overlap Arg1:T12 Arg2:T14	
R20	Overlap Arg1:T12 Arg2:T42	
T65	Quantifier_or_Qualifier 290 307	nuevo diagnóstico
#50	AnnotatorNotes T65	C1518321; Newly Diagnosed; Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T65	
R22	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T65	
R23	Has_Route_or_Mode Arg1:T18 Arg2:T51	
R24	Used_for Arg1:T18 Arg2:T17	
R25	Used_for Arg1:T43 Arg2:T17	
R26	Has_Route_or_Mode Arg1:T43 Arg2:T51	
R27	Used_for Arg1:T18 Arg2:T16	
R28	Used_for Arg1:T43 Arg2:T16	
R29	Experiences Arg1:T52 Arg2:T9	
R30	Speculation Arg1:T53 Arg2:T9	
R31	Speculation Arg1:T53 Arg2:T20	
R32	Experiences Arg1:T52 Arg2:T20	
R33	Overlap Arg1:T9 Arg2:T21	
R34	Overlap Arg1:T9 Arg2:T22	
R35	Overlap Arg1:T20 Arg2:T21	
R36	Overlap Arg1:T20 Arg2:T22	
R37	Negation Arg1:T62 Arg2:T22	
R38	Negation Arg1:T61 Arg2:T21	
R39	Experiences Arg1:T52 Arg2:T22	
R40	Experiences Arg1:T52 Arg2:T21	
T66	CONC 743 752	inclusión
#51	AnnotatorNotes T66	C1512693; Inclusion; Qualitative Concept
R41	Before Arg1:T41 Arg2:T66	
R42	Before Arg1:T41 Arg2:T24	
R43	Before Arg1:T41 Arg2:T25	
R44	Experiences Arg1:T56 Arg2:T26	
R45	Experiences Arg1:T56 Arg2:T44	
R46	Experiences Arg1:T56 Arg2:T27	
R47	Causes Arg1:T28 Arg2:T27	
T67	Quantifier_or_Qualifier 903 907	otra
#52	AnnotatorNotes T67	C0205394; Other; Qualitative Concept
R48	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T67	
R49	Experiences Arg1:T56 Arg2:T28	
R50	Experiences Arg1:T56 Arg2:T29	
R51	Location_of Arg1:T30 Arg2:T29	
R52	Causes Arg1:T32 Arg2:T27	
R53	Causes Arg1:T31 Arg2:T27	
R54	Experiences Arg1:T56 Arg2:T31	
R55	Experiences Arg1:T56 Arg2:T32	
#53	AnnotatorNotes T31	C5681332; Neurometabolic disease; Disease or Syndrome
R56	Causes Arg1:T59 Arg2:T33	
R57	Negation Arg1:T57 Arg2:T33	
T68	CONC 1055 1076	criterio de exclusión
A10	Assertion T68 Negated
#54	AnnotatorNotes T68	C0680251; Exclusion Criteria; Functional Concept 
R58	Negation Arg1:T57 Arg2:T68	
T69	Quantifier_or_Qualifier 1110 1121	en paralelo
#55	AnnotatorNotes T69	C0521115; Simultaneous; Temporal Concept
R59	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T69	
R62	Used_for Arg1:T45 Arg2:T37	
R63	Has_Duration_or_Interval Arg1:T45 Arg2:T63	
T70	CONC 1269 1283	inmediatamente
#56	AnnotatorNotes T70	C0205253; Immediate; Temporal Concept
R64	Overlap Arg1:T37 Arg2:T70	
R66	Overlap Arg1:T40 Arg2:T58	
T71	CONC 1345 1357	se permitirá
R67	Before Arg1:T70 Arg2:T39	
R60	Overlap Arg1:T34 Arg2:T35	
#57	AnnotatorNotes T17	C0149783; Steroid therapy; Therapeutic or Preventive Procedure
#58	AnnotatorNotes T37	C0149783; Steroid therapy; Therapeutic or Preventive Procedure
#59	AnnotatorNotes T39	C4684780; Standard Treatment; Health Care Activity
A11	Experiencer T47 Patient
A12	Experiencer T48 Patient
A13	Experiencer T52 Patient
A14	Experiencer T54 Family_member
A15	Experiencer T55 Other
A16	Experiencer T56 Patient
A17	Status T39 Future
T72	Result_or_Value 326 329	neg
R61	Has_Result_or_Value Arg1:T42 Arg2:T72	
